CSF2 and early-onset autosomal dominant Alzheimer disease: This is in agreement with previous studies that showed a neuroprotective effect of GM-CSF in animal models of Parkinson’s disease [40], Alzheimer’s disease [41], stroke [42], and TBI [43,44].